Solution modality / Gene Therapy

Supply the function a disease has taken away.

BioTwin’s gene-therapy templates frame the missing function, relevant isoform and expression requirement. Those choices help define the task for vector design and experimental development.

Current work Strategy templates

Which function needs replacing?

Define the missing function, relevant gene/isoform and expression context before choosing a vector or evaluating a program.

Gene addition and replacement

  • Functional gene addition or replacement

Templates for gene-therapy strategy

  • In BioTwin today · Gene-addition and replacement templates help frame the missing function and expression requirement. Delivery choices, including AAV, can be represented in the strategy.
  • Development and validation · Current coverage is strategy modeling. Vector engineering, expression control and biological validation remain distinct development requirements.

From expression requirement to vector development

Specify the missing function, the gene or isoform and the desired expression pattern. Evaluate the delivery and expression-control requirements with suitable vector and experimental expertise.

Related target and pathway assessment

Related research methods to explore; a combined modality-specific workflow is not yet established.

  • Isoform-Specific Target Assessment · Determine whether an isoform distinction changes the target, intervention or assay your program should use. Read the method
  • Resistance Min-Cut and Protein–RNA Co-Targeting · Investigate modeled signaling escape routes before choosing a protein–RNA co-targeting hypothesis. Read the method

Discuss Gene Therapy for your program

Start with the biological objective and the decision you need to make. We can establish which existing methods fit and what additional development would be required.